These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 29703551)

  • 21. Emergence of obsessive--compulsive symptoms and tics during clozapine withdrawal.
    Poyurovsky M; Bergman Y; Shoshani D; Schneidman M; Weizman A
    Clin Neuropharmacol; 1998; 21(2):97-100. PubMed ID: 9579295
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Managing clozapine discontinuation - acute and chronic maintenance strategies.
    Shields MK; Bastiampillai T; Mohan T
    Aust N Z J Psychiatry; 2012 Nov; 46(11):1104-5. PubMed ID: 23104931
    [No Abstract]   [Full Text] [Related]  

  • 23. Atypical antipsychotics and neuroleptic malignant syndrome.
    Velamoor VR
    Can J Psychiatry; 2001 Nov; 46(9):865-6. PubMed ID: 11761644
    [No Abstract]   [Full Text] [Related]  

  • 24. Withdrawal-emergent respiratory dyskinesia with risperidone treated with clozapine.
    Mendhekar DN; Inamdar A
    J Neuropsychiatry Clin Neurosci; 2010; 22(2):E24. PubMed ID: 20463136
    [No Abstract]   [Full Text] [Related]  

  • 25. Supersensitivity psychosis in a case with clozapine tolerance.
    Ozcan S; Soydan A; Tamam L
    Eur Rev Med Pharmacol Sci; 2012 Oct; 16 Suppl 4():70-3. PubMed ID: 23090814
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clozapine for the management of persistent catatonia.
    Tabbane K; Halayem S; Joober R
    J Psychiatry Neurosci; 2016 Oct; 41(6):E81-E82. PubMed ID: 27768562
    [No Abstract]   [Full Text] [Related]  

  • 27. Potential use of ipatropium bromide for the treatment of clozapine-induced hypersalivation: a preliminary report.
    Calderon J; Rubin E; Sobota WL
    Int Clin Psychopharmacol; 2000 Jan; 15(1):49-52. PubMed ID: 10836287
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Rebound insomnia after abrupt clozapine withdrawal.
    Staedt J; Stoppe G; Hajak G; Ruther E
    Eur Arch Psychiatry Clin Neurosci; 1996; 246(2):79-82. PubMed ID: 9063912
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fatal agranulocytosis 4 years after discontinuation of clozapine.
    Tiihonen J
    Am J Psychiatry; 2006 Jan; 163(1):161. PubMed ID: 16390912
    [No Abstract]   [Full Text] [Related]  

  • 30. Developed catatonia with rhabdomyolysis and exacerbated cardiac failure upon switching from clozapine to olanzapine owing to cardiomyopathy during clozapine medication - A case report.
    Ito Y; Murata M; Taku O; Fukuyama K; Motomura E; Dohi K; Okada M
    Asian J Psychiatr; 2023 Feb; 80():103376. PubMed ID: 36493522
    [No Abstract]   [Full Text] [Related]  

  • 31. [The concept of supersensitivity psychosis. The particular case of clozapine].
    Llorca PM; Penault F; Lançon C; Dufumier E; Vaiva G
    Encephale; 1999; 25(6):638-44. PubMed ID: 10668609
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neuroleptic malignant syndrome precipitated by haloperidol following clozapine discontinuation.
    Mendhekar DN; Jiloha RC
    Aust N Z J Psychiatry; 2005 Oct; 39(10):947-8. PubMed ID: 16168023
    [No Abstract]   [Full Text] [Related]  

  • 33. Clozapine monotherapy for catatonic schizophrenia: should clozapine be the treatment of choice, with catatonia rather than psychosis as the main therapeutic index?
    Dursun SM; Hallak JE; Haddad P; Leahy A; Byrne A; Strickland PL; Anderson IM; Zuardi AW; Deakin JF
    J Psychopharmacol; 2005 Jul; 19(4):432-3. PubMed ID: 15983003
    [No Abstract]   [Full Text] [Related]  

  • 34. Severe withdrawal akathisia following neuroleptic discontinuation successfully controlled by clozapine.
    Poyurovsky M; Hermesh H; Weizman A
    Int Clin Psychopharmacol; 1996 Dec; 11(4):283-6. PubMed ID: 9031996
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of anticholinergics in preventing acute deterioration in patients undergoing abrupt clozapine withdrawal.
    Seppälä N; Kovio C; Leinonen E
    CNS Drugs; 2005; 19(12):1049-55. PubMed ID: 16332145
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Severe extrapyramidal side effects when discontinuing clozapine and starting haloperidol.
    Bobba R
    Can J Psychiatry; 1997 Jun; 42(5):530. PubMed ID: 9220119
    [No Abstract]   [Full Text] [Related]  

  • 37. Low-dose glycopyrrolate for clozapine-associated sialorrhea.
    Praharaj SK; Munoli RN; Sharma PS
    J Clin Psychopharmacol; 2014 Jun; 34(3):392. PubMed ID: 24717248
    [No Abstract]   [Full Text] [Related]  

  • 38. Review of withdrawal catatonia: what does this reveal about clozapine?
    Lander M; Bastiampillai T; Sareen J
    Transl Psychiatry; 2018 Jul; 8(1):139. PubMed ID: 30065280
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clozapine withdrawal catatonia or lethal catatonia in a schizoaffective patient with a family history of Parkinson's disease.
    Thanasan S; Jambunathan ST
    Afr J Psychiatry (Johannesbg); 2010 Nov; 13(5):402, 404. PubMed ID: 21390412
    [No Abstract]   [Full Text] [Related]  

  • 40. Immediate recurrence of psychotic symptoms after discontinuation of clozapine: a case report.
    Tanríverdi N; Yazící KM
    Biol Psychiatry; 1996 May; 39(9):814-5. PubMed ID: 8731523
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.